ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $53,000 | -92.5% | 11,940 | -75.0% | 0.00% | -85.7% |
| Q4 2021 | $703,000 | -29.7% | 47,821 | 0.0% | 0.01% | +75.0% |
| Q3 2021 | $1,000,000 | -7.3% | 47,821 | -21.6% | 0.00% | -33.3% |
| Q2 2021 | $1,079,000 | -42.8% | 60,976 | -20.8% | 0.01% | -40.0% |
| Q1 2021 | $1,887,000 | -42.3% | 77,000 | -20.2% | 0.01% | -60.0% |
| Q4 2020 | $3,268,000 | +69.7% | 96,536 | +25.4% | 0.02% | +8.7% |
| Q3 2020 | $1,926,000 | -25.8% | 77,000 | 0.0% | 0.02% | -20.7% |
| Q2 2020 | $2,597,000 | – | 77,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |